van Geel AN - Search Results

1

Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.

van Akkooi AC, Bouwhuis MG, van Geel AN, Hoedemaker R, Verhoef C, Grunhagen DJ, Schmitz PI, Eggermont AM, de Wilt JH. van Akkooi AC, et al. Among authors: van geel an. Eur J Surg Oncol. 2007 Feb;33(1):102-8. doi: 10.1016/j.ejso.2006.10.032. Epub 2006 Dec 11. Eur J Surg Oncol. 2007. PMID: 17161577

2

Prognostic factors after cervical lymph node dissection for cutaneous melanoma metastases.

Grünhagen DJ, Eggermont AM, van Geel AN, Graveland WJ, deWilt JH. Grünhagen DJ, et al. Among authors: van geel an. Melanoma Res. 2005 Jun;15(3):179-84. doi: 10.1097/00008390-200506000-00006. Melanoma Res. 2005. PMID: 15917699

3

Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site.

Prens SP, van der Ploeg AP, van Akkooi AC, van Montfort CA, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C. Prens SP, et al. Among authors: van akkooi ac, van montfort ca, van geel an, van der ploeg ap. Ann Surg Oncol. 2011 Dec;18(13):3586-92. doi: 10.1245/s10434-011-1801-5. Epub 2011 May 25. Ann Surg Oncol. 2011. PMID: 21611857 Free PMC article.

4

TNF-based isolated limb perfusion in unresectable extremity desmoid tumours.

Grünhagen DJ, de Wilt JH, Verhoef C, van Geel AN, Eggermont AM. Grünhagen DJ, et al. Among authors: van geel an. Eur J Surg Oncol. 2005 Oct;31(8):912-6. doi: 10.1016/j.ejso.2005.07.002. Eur J Surg Oncol. 2005. PMID: 16098709

5

TNF dose reduction in isolated limb perfusion.

Grünhagen DJ, de Wilt JH, van Geel AN, Graveland WJ, Verhoef C, Eggermont AM. Grünhagen DJ, et al. Among authors: van geel an. Eur J Surg Oncol. 2005 Nov;31(9):1011-9. doi: 10.1016/j.ejso.2005.07.003. Epub 2005 Aug 15. Eur J Surg Oncol. 2005. PMID: 16099618

6

High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.

van Akkooi AC, de Wilt JH, Verhoef C, Graveland WJ, van Geel AN, Kliffen M, Eggermont AM. van Akkooi AC, et al. Among authors: van geel an. Eur J Cancer. 2006 Feb;42(3):372-80. doi: 10.1016/j.ejca.2005.10.023. Epub 2006 Jan 5. Eur J Cancer. 2006. PMID: 16403622

7

5-Year follow-up of sentinel node negative breast cancer patients.

de Kanter AY, Menke-Pluymers MM, Wouters MW, Burgmans I, van Geel AN, Eggermont AM. de Kanter AY, et al. Among authors: van geel an. Eur J Surg Oncol. 2006 Apr;32(3):282-6. doi: 10.1016/j.ejso.2005.11.014. Epub 2006 Jan 24. Eur J Surg Oncol. 2006. PMID: 16439094

8

Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha.

Grünhagen DJ, de Wilt JH, van Geel AN, Eggermont AM. Grünhagen DJ, et al. Among authors: van geel an. Eur J Surg Oncol. 2006 May;32(4):371-80. doi: 10.1016/j.ejso.2006.01.015. Epub 2006 Mar 7. Eur J Surg Oncol. 2006. PMID: 16520016 Review.

9

Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.

de Kanter AY, Menke-Pluijmers MB, Henzen-Logmans SC, van Geel AN, van Eijck CJ, Wiggers T, Eggermont AM. de Kanter AY, et al. Among authors: van eijck cj, van geel an. Eur J Surg Oncol. 2006 Jun;32(5):498-501. doi: 10.1016/j.ejso.2006.02.012. Epub 2006 Apr 3. Eur J Surg Oncol. 2006. PMID: 16580810

10

Sentinel node biopsy for clear cell sarcoma.

van Akkooi AC, Verhoef C, van Geel AN, Kliffen M, Eggermont AM, de Wilt JH. van Akkooi AC, et al. Among authors: van geel an. Eur J Surg Oncol. 2006 Nov;32(9):996-9. doi: 10.1016/j.ejso.2006.03.044. Epub 2006 May 2. Eur J Surg Oncol. 2006. PMID: 16672185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page